Results for "Understanding Pharmaceutical Distribution"
Three Healthcare Distribution Industry Trends To Watch
For nearly a century, the HDA Factbook has reported on the productivity behind the safe and effective delivery of millions of medicines and healthcare products nationwide. Published by the HDA Research Foundation, the latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings. A recent LinkedIn Live discussion provided additional perspective into the trends shaping the pharmaceutical distribution industry amid an evolving business environment.
HDA Statement on FDA Commissioner Nominee Dr. Robert Califf
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding President Biden’s nomination of Dr. Robert Califf as FDA Commissioner.
HDA’s President and CEO Chester “Chip” Davis, Jr., Testifies Before House Energy and Commerce Health Subcommittee on Generic Drug Shortages
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., testified before the House Energy and Commerce Subcommittee on Health during a legislative hearing on proposals to prevent and respond to generic drug shortages.